This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.RR Liberthson . Sudden death from cardiac causes in children and young adults. N Engl J Med 1996; 334: 1039–1044.
2.J Tfelt-Hansen , BG Winkel , M Grunnet , et al. Cardiac channelopathies and sudden infant death syndrome. Cardiology 2011; 119: 21–33.
3.D Corrado , F Migliore , M Bevilacqua , et al. Sudden cardiac death in athletes: can it be prevented by screening? Herz 2009; 34: 259–266.
4.BJ Maron , TE Gohman , D Aeppli . Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 1998; 32: 1881–1884.
5.D Corrado , C Basso , G Rizzoli , et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003; 42: 1959–1963.
6.G O'Donovan , AJ Blazevich , C Boreham , et al. The ABC of physical activity for health: a consensus statement from the British Association of Sport and Exercise Sciences. J Sports Sci 2010; 28: 573–591.
7.P Brugada , J Brugada . Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391–1396.
9.M Vatta , R Dumaine , G Varghese , et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002; 11: 337–345.
, C Wolpert
, AS Amin
, et al
. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website
). Heart Rhythm 2009
11.DP Zipes , AJ Camm , M Borggrefe , et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 746–837.
12.V Probst , I Denjoy , PG Meregalli , et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation 2007; 115: 2042–2048.
13.DP Zipes , MJ Ackerman , NA Estes 3rd, et al. Task Force 7: arrhythmias. J Am Coll Cardiol 2005; 45: 1354–1363.
14.PJ Schwartz , M Stramba-Badiale , L Crotti , et al. Prevalence of the congenital long-QT syndrome. Circulation 2009; 120: 1761–1767.
16.DM Roden . Keep the QT interval: it is a reliable predictor of ventricular arrhythmias. Heart Rhythm 2008; 5: 1213–1215.
. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J
1957; 54: 59–68.
18.JD Kapplinger , DJ Tester , BA Salisbury , et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm 2009; 6: 1297–1303.
19.I Goldenberg , AJ Moss , DR Peterson , et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation 2008; 117: 2184–2191.
20.I Gussak , P Brugada , J Brugada , et al. Idiopathic short QT interval: a new clinical syndrome? Cardiology 2000; 94: 99–102.
21.C Templin , JR Ghadri , JS Rougier , et al. Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6). Eur Heart J 2011; 32: 1077–1088.
22.R Brugada , K Hong , R Dumaine , et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 2004; 109: 30–35.
23.MH Gollob , CJ Redpath , JD Roberts . The short QT syndrome: proposed diagnostic criteria. J Am Coll Cardiol 2011; 57: 802–812.
24.C Antzelevitch , GD Pollevick , JM Cordeiro , et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007; 115: 442–449.
25.F Gaita , C Giustetto , F Bianchi , et al. Short QT Syndrome: a familial cause of sudden death. Circulation 2003; 108: 965–970.
26.DJ Tester , LJ Kopplin , ML Will , et al. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm 2005; 2: 1099–1105.
27.A Celiker , I Erdogan , T Karagoz , et al. Clinical experiences of patients with catecholaminergic polymorphic ventricular tachycardia. Cardiol Young 2009; 19: 45–52.
28.SG Priori , C Napolitano , M Memmi , et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002; 106: 69–74.
30.AA Wilde , CR Bezzina . Genetics of cardiac arrhythmias. Heart 2005; 91: 1352–1358.
31.DJ Tester , P Arya , M Will , et al. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing. Heart Rhythm 2006; 3: 800–805.
32.DJ Tester , MJ Ackerman . Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice. Circulation 2011; 123: 1021–1037.
. Sudden cardiac death in pediatrics. Curr Opin Pediatr
2008; 20: 517–521.
34.JM Bos , SR Ommen , MJ Ackerman . Genetics of hypertrophic cardiomyopathy: one, two, or more diseases? Curr Opin Cardiol 2007; 22: 193–199.
35.DJ Tester , MJ Ackerman . Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children. Annu Rev Med 2009; 60: 69–84.
36.BJ Maron . Hypertrophic cardiomyopathy. Lancet 1997; 350: 127–133.
37.JA Decker , JW Rossano , EO Smith , et al. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children. J Am Coll Cardiol 2009; 54: 250–254.
38.JP Moak , ES Leifer , D Tripodi , et al. Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events. Pediatr Cardiol 2011; 32: 1096–1105.
39.PO Lim , JA Morris-Thurgood , MP Frenneaux . Vascular mechanisms of sudden death in hypertrophic cardiomyopathy, including blood pressure responses to exercise. Cardiol Rev 2002; 10: 15–23.
40.HL Thomson , J Morris-Thurgood , J Atherton , et al. Reflex responses of venous capacitance vessels in patients with hypertrophic cardiomyopathy. Clin Sci (Lond) 1998; 94: 339–346.
41.M Santini , M Russo , G Botto , et al. Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI). Europace 2009; 11: 476–482.
42.P Melacini , BJ Maron , F Bobbo , et al. Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy. Heart 2007; 93: 708–710.
43.A Pelliccia , D Corrado , HH Bjornstad , et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil 2006; 13: 876–885.
44.E Pahl , LA Sleeper , CE Canter , et al. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy a report from the pediatric cardiomyopathy registry. J Am Coll Cardiol 2012; 59: 607–615.
45.JA Towbin , AM Lowe , SD Colan , et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006; 296: 1867–1876.
46.P Charron , M Arad , E Arbustini , et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2010; 31: 2715–2726.
47.JL Jefferies , JA Towbin . Dilated cardiomyopathy. Lancet 2010; 375: 752–762.
48.S Kass , C MacRae , HL Graber , et al. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet 1994; 7: 546–551.
49.MR Taylor , PR Fain , G Sinagra , et al. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 2003; 41: 771–780.
50.DS Herman , L Lam , MR Taylor , et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med 2012; 366: 619–628.
51.WP McNair , L Ku , MR Taylor , et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004; 110: 2163–2167.
52.JM Dupuis , A Tabib , P Reix , et al. [Sudden unexpected death of cardiac origin in the 6 to 18 years population. Pathologic data. Role of sports? How can we prevent it?]. Arch Pediatr 2005; 12: 1204–1208.
53.B Maisch , G Hufnagel , S Kolsch , et al. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Herz 2004; 29: 624–636.
54.JH van Berlo , WG de Voogt , AJ van der Kooi , et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl) 2005; 83: 79–83.
55.GD Williams , GB Hammer . Cardiomyopathy in childhood. Curr Opin Anaesthesiol 2011; 24: 289–300.
56.SW Denfield , SA Webber . Restrictive cardiomyopathy in childhood. Heart Fail Clin 2010; 6: 445–452, viii.
57.T Hayashi , E Tsuda , K Kurosaki , et al. Electrocardiographic and clinical characteristics of idiopathic restrictive cardiomyopathy in children. Circ J 2007; 71: 1534–1539.
58.S Sen-Chowdhry , P Syrris , WJ McKenna . Genetics of restrictive cardiomyopathy. Heart Fail Clin 2011; 6: 179–186.
60.FI Marcus , WJ McKenna , D Sherrill , et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010; 121: 1533–1541.
61.N Tiso , DA Stephan , A Nava , et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001; 10: 189–194.
62.G Thiene , D Corrado , C Basso . Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet J Rare Dis 2007; 2: 45.
63.MW Deyell , JG Andrade , BM McManus , et al. The other side of arrhythmogenic right ventricular cardiomyopathy. Can J Cardiol 2011; 27263: e213–e266.
64.B Bauce , A Nava , G Beffagna , et al. Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm 2010; 7: 22–29.
65.RM Hamilton . Arrhythmogenic right ventricular cardiomyopathy. Pacing Clin Electrophysiol 2009; 32 (Suppl 2): S44–S51.
66.PS Douglas , ML O'Toole , WD Hiller , et al. Different effects of prolonged exercise on the right and left ventricles. J Am Coll Cardiol 1990; 15: 64–69.
67.B Pinamonti , AM Dragos , SA Pyxaras , et al. Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. Eur Heart J 2011; 32: 1105–1113.
68.BJ Maron . Sudden death in young athletes. N Engl J Med 2003; 349: 1064–1075.
69.BJ Maron . Risk profiles and cardiovascular preparticipation screening of competitive athletes. Cardiol Clin 1997; 15: 473–483.
70.P Zeppilli , A dello Russo , C Santini , et al. In vivo detection of coronary artery anomalies in asymptomatic athletes by echocardiographic screening. Chest 1998; 114: 89–93.
71.PC Frommelt . Congenital coronary artery abnormalities predisposing to sudden cardiac death. Pacing Clin Electrophysiol 2009; 32 2 Suppl: S63–S66.
72.N Kinoshita , J Mimura , C Obayashi , et al. Aortic root dilatation among young competitive athletes: echocardiographic screening of 1929 athletes between 15 and 34 years of age. Am Heart J 2000; 139: 723–728.
73.RS Bader , L Goldberg , DJ Sahn . Risk of sudden cardiac death in young athletes: which screening strategies are appropriate? Pediatr Clin North Am 2004; 51: 1421–1441.
74.HL Tan , N Hofman , IM van Langen , et al. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005; 112: 207–213.
75.I Denjoy , JM Lupoglazoff , P Guicheney , et al. Arrhythmic sudden death in children. Arch Cardiovasc Dis 2008; 101: 121–125.
76.D Corrado , C Basso , A Pavei , et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006; 296: 1593–1601.
77.JA Drezner , JS Chun , KG Harmon , et al. Survival trends in the United States following exercise-related sudden cardiac arrest in the youth: 2000–2006. Heart Rhythm 2008; 5: 794–799.
78.D Corrado , C Schmied , C Basso , et al. Risk of sports: do we need a pre-participation screening for competitive and leisure athletes? Eur Heart J 2011; 32: 934–944.
79.BJ Maron . Hypertrophic cardiomyopathy in childhood. Pediatr Clin North Am 2004; 51: 1305–1346.
80.L Munoz , G Norgan , M Rauschhuber , et al. An exploratory study of cardiac health in college athletes. Appl Nurs Res 2009; 22: 228–235.
81.MR Kramer , Y Drori , B Lev . Sudden death in young soldiers. High incidence of syncope prior to death. Chest 1988; 93: 345–347.
82.MS Link , NA Mark Estes 3rd. Sudden cardiac death in athletes. Prog Cardiovasc Dis 2008; 51: 44–57.
83.GJ Balady , JB Cadigan , TJ Ryan . Electrocardiogram of the athlete: an analysis of 289 professional football players. Am J Cardiol 1984; 53: 1339–1343.
84.BJ Gersh , BJ Maron , RO Bonow , et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58: e212–e260.